These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3144167)

  • 41. Electrophysiology and long-term efficacy of pentisomide in patients with supraventricular tachycardia.
    Kühlkamp V; Mewis C; Seipel L
    Int J Cardiol; 1992 Jul; 36(1):69-79. PubMed ID: 1428255
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia].
    Manz M; Beermann J; Gerckens U; Lüderitz B
    Z Kardiol; 1986 Dec; 75(12):757-63. PubMed ID: 3825226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Electrophysiology in assessing supraventricular arrhythmias: value of programmed stimulation in predicting and understanding efficacy of encainide.
    Wellens HJ; Brugada P
    Am J Cardiol; 1986 Aug; 58(5):37C-40C. PubMed ID: 3092617
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Electrophysiologic and clinical effects of flecainide for recurrent paroxysmal supraventricular tachycardia.
    Hoff PI; Tronstad A; Oie B; Ohm OJ
    Am J Cardiol; 1988 Sep; 62(9):585-9. PubMed ID: 3137798
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Flecainide in the Wolff-Parkinson-White syndrome.
    Crozier I
    Am J Cardiol; 1992 Aug; 70(5):26A-32A. PubMed ID: 1509995
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical electrophysiologic effects of lorcainide in patients and its effect on the conduction of accessory pathway in Wolff-Parkinson-White syndrome].
    Jiang H
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Jun; 18(3):157-9, 190. PubMed ID: 2086169
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of tocainide, encainide, lorcainide and flecainide for supraventricular arrhythmias.
    Orning OM
    Eur Heart J; 1984 Sep; 5 Suppl B():81-6. PubMed ID: 6437821
    [No Abstract]   [Full Text] [Related]  

  • 48. Intravenous 3-methoxy-O-desmethyl-encainide in reentrant supraventricular tachycardia: a randomized double-blind placebo-controlled trial in patients undergoing EP study.
    Ware DL; Lee JT; Murray KT; Hanyok JJ; Roden DM; Echt DS
    Pacing Clin Electrophysiol; 1991 Sep; 14(9):1343-50. PubMed ID: 1720527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of encainide and quinidine for supraventricular tachyarrhythmias.
    Mäkynen PJ; Koskinen PJ; Saaristo TE; Liisanantti RK
    Am J Cardiol; 1988 Dec; 62(19):55L-59L. PubMed ID: 3144169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [AV reciprocating tachycardia with intermittent bundle branch block in latent Wolff-Parkinson-White syndrome].
    Veress G
    Orv Hetil; 1994 May; 135(21):1131-6. PubMed ID: 7910681
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Electrophysiology of oral encainide.
    Jackman WM; Zipes DP; Naccarelli GV; Rinkenberger RL; Heger JJ; Prystowsky EN
    Am J Cardiol; 1982 Apr; 49(5):1270-8. PubMed ID: 6801954
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cibenzoline: electrophysiologic effects of a new class I anti-arrhythmia agents in supraventricular tachycardia].
    Pfitzner P; Manz M; Schütz R; Lüderitz B
    Z Kardiol; 1989 Oct; 78(10):654-60. PubMed ID: 2686252
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Supraventricular tachycardias: mechanism, diagnosis and therapy].
    Osswald S; Buser PT; Rickenbacher P; Pfisterer M
    Schweiz Med Wochenschr; 1996 Jun; 126(22):974-85. PubMed ID: 8693318
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Wolff-Parkinson-White syndrome with orthodromic supraventricular tachycardia associated with a "hyper-conductor" atrio-ventricular node. A therapeutic challenge].
    Hernández González D; Iturralde Torres P; Romero L; Colín L; Villarreal A; González Hermosillo JA
    Arch Inst Cardiol Mex; 1990; 60(2):175-81. PubMed ID: 2378538
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Oct; 31(10):1227-43. PubMed ID: 9337449
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Slow and fast AV nodal pathways in tachycardia complicating Wolff-Parkinson-White syndrome: report of a case].
    Vitale P; Santangelo L; Vitale N; Nave C; Civitillo UF; Curcio N; Iacono A
    Cardiologia; 1992 Nov; 37(11):775-80. PubMed ID: 1298547
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Use of digoxin in patients with paroxysmal supraventricular tachycardia].
    Smetnev AS; Titov VN; Shevchenko NM; Gurevich EM
    Kardiologiia; 1989 Apr; 29(4):61-4. PubMed ID: 2666709
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sotalol in patients with Wolff-Parkinson-White syndrome.
    Kunze KP; Schlüter M; Kuck KH
    Circulation; 1987 May; 75(5):1050-7. PubMed ID: 3568305
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Use of transesophageal left atrial cardiac pacing for assessment of cordarone effectiveness in patients with atrioventricular tachycardia].
    Matiushin GV; Shul'man VA; Balog AI; Golovenkin SE; Bezruk AP; Ivanitskiĭ EA; Smirnova OV
    Ter Arkh; 1998; 70(6):47-50. PubMed ID: 9695227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Usefulness of predischarge electrophysiologic study in predicting late outcome after surgical ablation of the accessory pathway in the Wolff-Parkinson-White syndrome.
    Yeh SJ; Wang CC; Lin FC; Chang JP; Chang CH; Wu D
    Am J Cardiol; 1992 Apr; 69(9):909-12. PubMed ID: 1550021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.